Clinical Trial Update: Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating dose-finding, pharmacokinetics, safety and tolerability of oritavancin in pediatric participants with suspected or confirmed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Bacterial Infections

Drugs mentioned

• Oritavancin (oritavancin)

Snippet

Sponsor: Melinta Therapeutics, LLC | Conditions: Gram-positive Bacterial Infections | Phase 1 | Status: COMPLETED